Publication | Closed Access
Rapsody: randomized prospective phase II trial of two schedules of sorafenib daily and interferon-α 2A (IFN) in metastatic renal cell carcinoma (MRCC). GOIRC study 0681
23
Citations
0
References
2007
Year
UrologyGenitourinary CancerMedicineGoirc Study 0681Cancer TreatmentOncologyRadiation OncologyMolecular OncologyInterferon-α 2A
No additional data available for this publication yet. Check back later!